Aging and mental health Article Personality disorders 
Psychiatric Times
JULY 1, 2025
SHOW MORE The FDA will update ADHD medication labels, warning of weight loss risks in children under 6, urging careful monitoring by health care professionals. Healthcare professionals should monitor weight and growth in young patients on these medications and consider alternative treatments if adverse effects occur.
Psychiatric Times
JULY 7, 2025
Learn more in this exclusive article. Together, they will aim to bring innovative mental health treatments to patients in need. Cobenfy failed to meet the primary endpoint in a phase 3 trial for schizophrenia, but showed numerical improvement, warranting further investigation.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Psychiatric Times
JUNE 12, 2025
Follow the age-old axiom of “say what you’re going to say, say it, and then say what you said.” Author(s): Joseph F. Goldberg, MD , Stephen M. Stahl, MD, PhD, DSc (Hon) Now more than ever, capturing and scaling the ingredients that make for compelling and impactful teaching for trainees is vital to our future.
Psychiatric Times
JUNE 23, 2025
This article explores how different generations approach psychiatric training, the benefits and challenges technology introduces, and the leadership implications of these changes. As the newest cohort in psychiatric training, they are digital natives, accustomed to rapid information retrieval, online simulations, and mental health apps.
Psychiatric Times
JULY 2, 2025
FDA Indications, Potential Future Indications, and Areas of Investigation for GLP-1 RAs Soon after their introduction, GLP-1 RAs’ significant weight-lowering effects and health benefits in other medical disorders became apparent, with relatively greater metabolic and weight loss benefits reported with newer GLP-1 RAs and dual agonists.
Mad in America
APRIL 16, 2025
Dr. Teralyn Sell is a distinguished expert in Psychology and Brain Health, holding a PhD in Psychology and an MS in Counseling Psychology. She bridges the gap between traditional mental health care and integrative brain health solutions with formal training in holistic nutrition and biology.
Psychiatric Times
JUNE 18, 2025
Given her young age and the described alterations in her behavior and cognition, these can be viewed as prodromal symptoms. The DSM-5 task force concluded that there was not enough evidence to justify incorporating APS as an official mental disorder diagnosis in Section II.
Expert insights. Personalized for you.
98 
Let's personalize your content